Barriers and facilitators for screening and treatment of hyperlipidemia among patients with inflammatory arthritis

Barriers and facilitators for screening and treatment of hyperlipidemia among patients with inflammatory arthritis

Abstract Background Patients with inflammatory arthritis (IA), defined as rheumatoid arthritis (RA) and psoriatic arthritis (PsA), are at increased risk for cardiovascular disease (CVD). The frequency of screening and treatment of hyperlipidemia, a modifiable CVD risk factor, is low in these patient...

Full description

Bibliographic Details
Main Authors: Iris Navarro-Millán, Sarah R. Young, Sally Shurbaji, Chastity McDavid, Anna Cornelius-Schecter, Bernadette Johnson, Andrea L. Cherrington, Liana Fraenkel, Susan M. Goodman, Jeffrey R. Curtis, Shilpa Venkatachalam, Monika M. Safford
Format: Article
Language:English
Published: BMC 2020-06-01
Series:BMC Rheumatology
Subjects:
Cardiovascular disease
Rheumatoid arthritis
Psoriatic arthritis
Hyperlipidemia
Peer coaches
Social support
Online Access:http://link.springer.com/article/10.1186/s41927-020-00123-w

Internet

http://link.springer.com/article/10.1186/s41927-020-00123-w

Similar Items